Manuscripts
Showing 1521 manuscripts.
Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
Citation
Lee Fairlie, Miriam Chernoff, Mark F. Cotton, Mutsa Bwakura-Dangarembizi, Avy Violari, Itziar Familiar-Lopez, Linda Barlow-Mosha, Portia Kamthunzi, Katie Mccarthy, Patrick Jean-Philippe, Barbara Laughton, Paul E Palumbo, Michael J Boivin. Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa. Frontiers in Pediatrics. 2022. 10: 899002. PMID: 35989995Journal
Frontiers in Pediatrics
Study
P1104s
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
Citation
Kristin Baltrusaitis, Bonus Makanani, Camlin Tierney, Mary Glenn Fowler, Dhayendre Moodley, Gerhard Theron, Lynette H Nyakudya, Musunga Tomu, Lee Fairlie, Kathleen George, Barbra Heckman, Kevin Knowles, Renee Browning, George K Siberry, Taha E Taha, Lynda Stranix-Chibanda, PROMISE P1084s Study Team. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infectious Diseases. 2022. 22: 634. PMID: 35858874Year
2022
Journal
BMC Infectious Diseases
Study
P1084s
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
Citation
Martina Penazzato, Shahin Lockman, Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022. 25: e25912. PMID: 35851834Journal
Journal of the International AIDS Society
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.
Citation
Mbandi SK, Painter H, Penn-Nicholson A, Toefy A, Erasmus M, Hanekom WA, Scriba TJ, Lai RPJ, Marais S, Fletcher HA, Meintjes G, Wilkinson RJ, Cotton MF, Pahwa S, Cameron MJ, Nemes E. Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.. European Journal of Immunology. 2022. 52: 1112-1119. PMID: 35398886Journal
European Journal of Immunology
Coordination of inflammatory responses in children with perinatally acquired HIV infection
Citation
Adriana Weinberg, Mark J. Giganti, Patricia A. Sirois, Grace Montepiedra, Jennifer Canniff, Allison Agwu, Michael J. Boivin, Suad Kapetanovic, Mark J. Abzug, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network. Coordination of inflammatory responses in children with perinatally acquired HIV infection. AIDS. 2022. 36: 1117-1127. PMID: 35442223Journal
AIDS
Study
P1104s, P1060
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Citation
Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. 90: 343-350. PMID: 35195573Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants
Citation
Ceejay L. Boyce, Tatiana Sils, Daisy Ko, Annie Wong-on-Wing, Ingrid A. Beck, Sheila M. Styrchak, Patricia DeMarrais, Camlin Tierney, Lynda Stranix-Chibanda, Patricia M. Flynn, Taha E. Taha, Maxensia Owor, Mary Glenn Fowler, Lisa M. Frenkel. Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants. Clinical Infectious Diseases. 2022. 74: 2001-2009. PMID: 34467974Year
2022
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF
Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk
Citation
Buyisile Mkhize, Tracy Kellermann, Jennifer Norman, Sandra Castel, Anton Joubert, Kelly E. Dooley, Jyoti S. Mathad, Lubbe Wiesner. Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk. Journal of Pharmaceutical and Biomedical Analysis. 2022. 215PMID: 35462285Journal
Journal of Pharmaceutical and Biomedical Analysis
Study
IMPAACT 2001
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Citation
Jyoti S Mathad, Rada Savic, Paula Britto, Priya Jayachandran, Lubbe Wiesner, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Amphan Chalermchockcharoentkit, Portia Kamthunzi, Amita Gupta, Kelly E Dooley, IMPAACT 2001 Study Team. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022. PMID: 34323955Journal
Clinical Infectious Diseases
Study
IMPAACT 2001
Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial
Citation
Theodore D. Ruel, Edward P. Acosta, Jessica P. Liu, Kathryn P. Gray, Kathleen George, Nicole Montañez, Stephanie Popson, Ann M. Buchanan, Mattie Bartlett, Dale Dayton, Patricia Anthony, Cynthia Brothers, Cynthia Vavro, Rajendra Singh, Lucy Koech, Tichaona Vhembo, Rohan Hazra, Ellen Townley, Andrew Wiznia, IMPAACT P1093 Team. Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial. Lancet HIV. 2022. PMID: 35489377Journal
Lancet HIV
Study
P1093